Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 11, 2002 - Issue 10
Submit an article Journal homepage
921
Views
68
CrossRef citations to date
0
Altmetric
Drug Evaluation

Escitalopram

William J Burke University of Nebraska Department of Psychiatry, 985580 Nebraska Medical Center, Omaha, NE 68198-5580, USA
Pages 1477-1486 | Published online: 24 Feb 2005

Citations (68)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Qiuying Li, Hua Huo, Wenli Hu, Yin Sui & Yunbiao Tang. (2020) Comparison of Bioavailability and Bioequivalence of Generic and Brand Name Formulations of Escitalopram Oxalate Tablets in Healthy Chinese Population Under Fasting and Fed Conditions. Drug Design, Development and Therapy 14, pages 5167-5177.
Read now
Donatella Marazziti, Maria Teresa Avella, Lucia Basile, Federico Mucci & Liliana Dell’Osso. (2019) Pharmacokinetics of serotonergic drugs: focus on OCD. Expert Opinion on Drug Metabolism & Toxicology 15:4, pages 261-273.
Read now
Behzat Cimen, Cihan Banu Gumus, Ihsan Cetin, Saliha Ozsoy, Murat Aydin & Leyla Cimen. (2015) The Effects of Escitalopram Treatment on Oxidative/ Antioxidative Parameters in Patients with Depression. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 25:3, pages 272-279.
Read now
Eric Q. Wu, Rym Ben-Hamadi, Andrew P. Yu, Jackson Tang, M. Haim Erder & Anjana Bose. (2010) Healthcare utilization and costs incurred by patients with major depression after being switched from escitalopram to another SSRI for non-medical reasons. Journal of Medical Economics 13:2, pages 314-323.
Read now
Eric Wu, Paul Greenberg, Elaine Yang, Andrew Yu, Rym Ben-Hamadi & M. Haim Erder. (2008) Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants. Current Medical Research and Opinion 24:10, pages 2805-2813.
Read now
Dawson W Hedges & Fu Lye M Woon. (2007) An emerging role for escitalopram in the treatment of obsessive-compulsive disorder. Neuropsychiatric Disease and Treatment 3:4, pages 455-461.
Read now
Silvio R Bareggi, Emanuela Mundo, Bernardo Dell'Osso & A Carlo Altamura. (2007) The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders. Expert Opinion on Drug Metabolism & Toxicology 3:5, pages 741-753.
Read now
Hochang B. Lee, Constantine G. Lyketsos & Vani Rao. (2003) Pharmacological management of the psychiatric aspects of traumatic brain injury. International Review of Psychiatry 15:4, pages 359-370.
Read now
Frank P Bymaster, Robert K McNamara & Pierre V Tran. (2003) New approaches to developing antidepressants by enhancing monoaminergic neurotransmission. Expert Opinion on Investigational Drugs 12:4, pages 531-543.
Read now

Articles from other publishers (59)

Bo Yuan, Dameng Yang, Ge Qu, Nicholas J. Turner & Zhoutong Sun. (2024) Biocatalytic reductive aminations with NAD(P)H-dependent enzymes: enzyme discovery, engineering and synthetic applications. Chemical Society Reviews.
Crossref
Meng-Yao Wu, Fan-Zhi Bu, Yu Yu, Yue-Ming Yu, Zhi-Yong Wu, Cui-Wei Yan & Yan-Tuan Li. (2022) The comparison researches of cis/trans-butenedioic acids in regulating solid crystalline forms and improving pharmaceutical properties of antifungal drug econazole. Journal of Molecular Structure 1263, pages 133183.
Crossref
Li-Jeng Chen, Tsai-Ching Hsu, Hsiang-Lin Chan, Chiao-Fan Lin, Jing-Yu Huang, Robert Stewart, Bor-Show Tzang & Vincent Chin-Hung Chen. (2022) Protective Effect of Escitalopram on Hepatocellular Carcinoma by Inducing Autophagy. International Journal of Molecular Sciences 23:16, pages 9247.
Crossref
Caroline W. Espinola, Yuelee Khoo, Roohie Parmar, Ilya Demchenko, Benicio N. Frey, Roumen V. Milev, Arun V. Ravindran, Sagar V. Parikh, Keith Ho, Susan Rotzinger, Wendy Lou, Raymond W. Lam, Sidney H. Kennedy & Venkat Bhat. (2022) Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy. Brain and Behavior 12:5.
Crossref
Kazuyuki Nakagome, Yuma Yokoi, Atsuo Nakagawa, Masayuki Tani, Gentaro Nishioka, Naoki Yoshimura, Toshiaki A. Furukawa, Koichiro Watanabe, Masaru Mimura, Akira Iwanami & Takayuki Abe. (2021) Acceptability of escitalopram versus duloxetine in outpatients with depression who did not respond to initial second-generation antidepressants: A randomized, parallel-group, non-inferiority trial. Journal of Affective Disorders 282, pages 1011-1020.
Crossref
Stephen M. Stahl. 2021. Prescriber's Guide. Prescriber's Guide 269 274 .
Stephen M. Stahl. 2021. Prescriber's Guide. Prescriber's Guide.
Pedro Paulo Santos & William Heggie. 2020. Retrosynthesis in the Manufacture of Generic Drugs. Retrosynthesis in the Manufacture of Generic Drugs 85 140 .
Manfred Klöbl, Gregor Gryglewski, Lucas Rischka, Godber Mathis Godbersen, Jakob Unterholzner, Murray Bruce Reed, Paul Michenthaler, Thomas Vanicek, Edda Winkler-Pjrek, Andreas Hahn, Siegfried Kasper & Rupert Lanzenberger. (2020) Predicting Antidepressant Citalopram Treatment Response via Changes in Brain Functional Connectivity After Acute Intravenous Challenge. Frontiers in Computational Neuroscience 14.
Crossref
Deirdre Caffrey, Gillian Sowden & Cybele Arsan. (2020) A Possible Case of Escitalopram-Induced Tardive Dystonia. Psychosomatics 61:2, pages 188-192.
Crossref
Yuma Yokoi, Atsuo Nakagawa, Naoki Yoshimura, Toshiaki A. Furukawa, Masaru Mimura, Akira Iwanami, Takayuki Abe & Kazuyuki Nakagome. (2019) Acceptability of escitalopram versus duloxetine in outpatients with depression who did not respond to initial second‐generation antidepressants: Study protocol for a randomized, parallel‐group, non‐inferiority trial. Neuropsychopharmacology Reports 39:4, pages 262-272.
Crossref
Mariel Pietri, Alaeddine Djillani, Jean Mazella, Marc Borsotto & Catherine Heurteaux. (2019) First evidence of protective effects on stroke recovery and post-stroke depression induced by sortilin-derived peptides. Neuropharmacology 158, pages 107715.
Crossref
Anna K. Schmidtner, David A. Slattery, Joachim Gläsner, Andreas Hiergeist, Katharina Gryksa, Victoria A. Malik, Julian Hellmann-Regen, Isabella Heuser, Thomas C. Baghai, André Gessner, Rainer Rupprecht, Barbara Di Benedetto & Inga D. Neumann. (2019) Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner. Translational Psychiatry 9:1.
Crossref
Arash Mowla, Farzaneh Modarresi & Seyed Ali Dastgheib. (2018) Comparing escitaloipram with sertraline for obsessive and compulsive symptoms in patients with obsessive compulsive disorder: A comparative double blind clinical trial. Asian Journal of Psychiatry 38, pages 92-95.
Crossref
I YuanChi‑Ting HorngVincent ChenChun‑Hung ChenLi‑Jeng ChenTsai‑Ching HsuBor‑Show Tzang. (2017) Escitalopram oxalate inhibits proliferation and migration and induces apoptosis in non-small cell lung cancer cells. Oncology Letters.
Crossref
Euitae Kim, Oliver D. Howes, Bo-Hyung Kim, Myong-Wuk Chon, Seongho Seo, Federico E. Turkheimer, Jae Sung Lee, Yun-Sang Lee & Jun Soo Kwon. (2016) Regional Differences in Serotonin Transporter Occupancy by Escitalopram: An [11C]DASB PK-PD Study. Clinical Pharmacokinetics 56:4, pages 371-381.
Crossref
Young Min Choe, Ki Woong Kim, Jin Hyeong Jhoo, Seung Ho Ryu, Eun Hyun Seo, Bo Kyung Sohn, Min Soo Byun, Jae-Hwa Bak, Jong-Min Lee, Hyuk Jin Yun, Myeong-il Han, Jong Inn Woo & Dong Young Lee. (2016) Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease. International Journal of Geriatric Psychiatry 31:7, pages 731-739.
Crossref
Yangfeng Peng, Quan Sophia He & Jiang Cai. (2016) Enantioseparation of Citalopram by RP-HPLC, Using Sulfobutyl Ether- β -Cyclodextrin as a Chiral Mobile Phase Additive . International Journal of Analytical Chemistry 2016, pages 1-7.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 317 337 .
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 383 387 .
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 111 143 .
Agorastos Agorastos, Michael Kellner, Oliver Stiedl, Christoph Muhtz, Klaus Wiedemann & Cüneyt Demiralay. (2015) Blunted autonomic reactivity to pharmacological panic challenge under long-term escitalopram treatment in healthy men. International Journal of Neuropsychopharmacology 18:5.
Crossref
Miguel M. Santos, Igor Marques, Sílvia Carvalho, Cristina Moiteiro & Vítor Félix. (2015) Recognition of bio-relevant dicarboxylate anions by an azacalix[2]arene[2]triazine derivative decorated with urea moieties. Organic & Biomolecular Chemistry 13:10, pages 3070-3085.
Crossref
Gabriel Nowak, Lucyna Pomierny-Chamioło, Agata Siwek, Ewa Niedzielska, Bartosz Pomierny, Agnieszka Pałucha-Poniewiera & Andrzej Pilc. (2014) Prolonged administration of antidepressant drugs leads to increased binding of [3H]MPEP to mGlu5 receptors. Neuropharmacology 84, pages 46-51.
Crossref
Ming Chang, Gunnel Tybring, Marja-Liisa Dahl & Jonatan D. Lindh. (2014) Impact of Cytochrome P450 2C19 Polymorphisms on Citalopram/Escitalopram Exposure: A Systematic Review and Meta-Analysis. Clinical Pharmacokinetics 53:9, pages 801-811.
Crossref
Rajeev Jain, Dhanjai & Sanjay Sharma. (2013) Bismuth (III) oxide/glassy carbon sensor for sensing of antidepressant drug escitalopram in micellar media. Colloids and Surfaces A: Physicochemical and Engineering Aspects 436, pages 178-184.
Crossref
Hsiang-Wei Kuo, Shu Chih Liu, Hsiao-Hui Tsou, Sheng-Wen Liu, Keh-Ming Lin, Shao-Chun Lu, Mei-Chun Hsiao, Chin-Fu Hsiao, Chia-Yih Liu, Chia-Hui Chen, Mong-Liang Lu, Winston W Shen, Hwa-Sheng TangShen-Ing Liu, Liang-Huey Chang, Hsiao-Yu Wu, Yao-Sheng Chang, Teng-Kuang Yeh, Andrew CH Chen & Yu-Li Liu. (2013) CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions . Pharmacogenomics 14:10, pages 1191-1201.
Crossref
Howard S. Smith & Marco Pappagallo. 2012. Essential Pain Pharmacology. Essential Pain Pharmacology 161 165 .
Xiaolan Deng, Joris De Wolf, Ruud Vervoort, Dirk Pamperin, Erwin Adams & Ann Van Schepdael. (2012) Development and validation of a capillary electrophoresis method for the determination of escitalopram and sensitive quantification of its enantiomeric impurity in formulations. ELECTROPHORESIS 33:11, pages 1648-1651.
Crossref
J. Bléhaut, P. Franco, T. Zhang, E. Lang, E. Valéry & J.-F. Marcoux. 2012. Comprehensive Chirality. Comprehensive Chirality 400 456 .
Heidi Lopez de Diego, Andrew D. Bond & Robert James Dancer. (2011) Formation of solid solutions between racemic and enantiomeric citalopram oxalate. Chirality 23:5, pages 408-416.
Crossref
Barbara Drueke, Maren Boecker, Sonja Schlaegel, Olaf Moeller, Christoph Hiemke, Gerhard Gründer & Siegfried Gauggel. (2010) Serotonergic modulation of response inhibition and re‐engagement? Results of a study in healthy human volunteers. Human Psychopharmacology: Clinical and Experimental 25:6, pages 472-480.
Crossref
Barbara Drueke, Julia Baetz, Maren Boecker, Olaf Moeller, Christoph Hiemke, Gerd Gründer & Siegfried Gauggel. (2009) Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study. Psychopharmacology 207:2, pages 213-223.
Crossref
Siegfried Kasper, David S. Baldwin, Sara Larsson Lönn & Jean-Philippe Boulenger. (2009) Superiority of escitalopram to paroxetine in the treatment of depression. European Neuropsychopharmacology 19:4, pages 229-237.
Crossref
Michael Kellner, Christoph Muhtz, Cüneyt Demiralay, Jana Husemann, Wiebke Koelsch, Alexander Yassouridis & Klaus Wiedemann. (2009) The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype. Journal of Psychiatric Research 43:6, pages 642-648.
Crossref
. 2009. Meyler's Side Effects of Psychiatric Drugs. Meyler's Side Effects of Psychiatric Drugs 1 184 .
Jimmie C. Holland*Yesne Alici-Evcimen. 2009. Supportive Care in Cancer Therapy. Supportive Care in Cancer Therapy 139 151 .
Michael Kellner, Cüneyt Demiralay, Christoph Muhtz, Jana Husemann, Wiebke Kölsch, Christoph Hiemke, Alexander Yassouridis & Klaus Wiedemann. (2008) No effect of six weeks of treatment with escitalopram on mood in healthy volunteers — Irrespective of genotype for the promoter of the serotonin transporter. Psychiatry Research 161:3, pages 339-343.
Crossref
Staffan Ohlsson Rosenborg, Jessica Mwinyi, Maria Andersson, R. Michael Baldwin, Rasmus Steen Pedersen, Sarah C. Sim, Leif Bertilsson, Magnus Ingelman-Sundberg & Erik Eliasson. (2008) Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects. European Journal of Clinical Pharmacology 64:12, pages 1175-1179.
Crossref
Giampietro Frison, Donata Favretto, Susanna Vogliardi, Claudio Terranova & Santo Davide Ferrara. (2008) Quantification of Citalopram or Escitalopram and Their Demethylated Metabolites in Neonatal Hair Samples by Liquid Chromatography-Tandem Mass Spectrometry. Therapeutic Drug Monitoring 30:4, pages 467-473.
Crossref
Johan Lundberg, Jacob Strøyer Christophersen, Kamilla Buchberg Petersen, Henrik Loft, Christer Halldin & Lars Farde. (2007) PET measurement of serotonin transporter occupancy: a comparison of escitalopram and citalopram. The International Journal of Neuropsychopharmacology 10:06.
Crossref
R. Bordet. (2007) Une pharmacologie des antidépresseurs à revisiter : l’exemple du escitalopram. L'Encéphale 33, pages 127-133.
Crossref
Silvio R Bareggi, Emanuela Mundo, Bernardo Dell'Osso & A Carlo Altamura. (2007) The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders. Expert Opinion on Drug Metabolism & Toxicology 3:5, pages 741-753.
Crossref
Amanda Galvão-de Almeida, Lucas C. Quarantini, Cristianne R. Góis, Rogério Santos-Jesus, Ângela M.A. Miranda-Scippa, Irismar R. de Oliveira, Helena da Silva Prado, James F. Leckman & Maria C. Rosário. (2014) Obsessive-Compulsive Disorder: An Open-Label Pilot Trial of Escitalopram . CNS Spectrums 12:7, pages 519-524.
Crossref
Chandrashekar R. Elati, Naveenkumar Kolla, Pravinchandra J. Vankawala, Srinivas Gangula, Subrahmanyeswarara Chalamala, Venkatraman Sundaram, Apurba Bhattacharya, Himabindu Vurimidi & Vijayavitthal T. Mathad. (2007) Substrate Modification Approach to Achieve Efficient Resolution:  Didesmethylcitalopram:  A Key Intermediate for Escitalopram. Organic Process Research & Development 11:2, pages 289-292.
Crossref
Niranjan Rao. (2007) The Clinical Pharmacokinetics of Escitalopram. Clinical Pharmacokinetics 46:4, pages 281-290.
Crossref
Abbey Maul & Abbey Maul. 2007. xPharm: The Comprehensive Pharmacology Reference. xPharm: The Comprehensive Pharmacology Reference 1 5 .
Yvonne Kuepper, Sandra Bausch, Jona Iffland, Martin Reuter & Juergen Hennig. (2006) S-Citalopram in neuroendocrine challenge-tests: Serotonergic responsivity in healthy male and female human participants. Psychoneuroendocrinology 31:10, pages 1200-1207.
Crossref
Johan Lundberg, Christer Halldin & Lars Farde. (2006) Measurement of serotonin transporter binding with PET and [ 11 C]MADAM: A test–retest reproducibility study . Synapse 60:3, pages 256-263.
Crossref
Kenneth L. Kirk. (2006) Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules. Journal of Fluorine Chemistry 127:8, pages 1013-1029.
Crossref
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions 3109 3117 .
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions 794 797 .
Magnus W. Walter. (2005) Monoamine reuptake inhibitors: highlights of recent research developments. Drug Development Research 65:3, pages 97-118.
Crossref
Larry Ereshefsky, Stanford Jhee & Dale Grothe. (2005) Antidepressant Drug-Drug Interaction Profile Update. Drugs in R & D 6:6, pages 323-336.
Crossref
Alastair J Flint. (2005) Generalised Anxiety Disorder in Elderly Patients. Drugs & Aging 22:2, pages 101-114.
Crossref
Sonu Sundd Singh, Hiten Shah, Sapna Gupta, Manish Jain, Kuldeep Sharma, Purav Thakkar & Ruchy Shah. (2004) Liquid chromatography–electrospray ionisation mass spectrometry method for the determination of escitalopram in human plasma and its application in bioequivalence study. Journal of Chromatography B 811:2, pages 209-215.
Crossref
Gregory M Asnis, Shari R Kohn, Margaret Henderson & Nicole L Brown. (2004) SSRIs versus Non-SSRIs in Post-traumatic Stress Disorder. Drugs 64:4, pages 383-404.
Crossref
Catherine C Crone & Geoffrey M Gabriel. (2004) Treatment of Anxiety and Depression in Transplant Patients. Clinical Pharmacokinetics 43:6, pages 361-394.
Crossref
Cécile Boyer-Joubert, Edwige Lorthiois & François Moreau. 2003. 347 374 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.